NEW YORK (TheStreet) -- Merck (MRK - Get Report) stock is lower by 1.33% to $53.29 in afternoon trading on Tuesday, even though the company is raising its quarterly dividend. Merck's board has approved a 1 cent …
The Street · 1 day ago
Dividend Hike
Consistently, one of the more popular stocks people enter into their stock options watchlist at Stock Options Channel is Merck & Co., Inc (Symbol: MRK). So this week we highlight one interesting put contract, and one interesting call contract, from the ...
NASDAQ · 11/16/2015
Stock Options
Traders purchased shares of Merck & Co. (NYSE:MRK) on weakness during trading hours on Friday, reports. $98.81 million flowed into the stock on the tick-up and $49.55 million flowed out …
Ticker Report · 11/21/2015
More from Bing News
Dow Jones component Merck & Co. Inc. (MRK) saw its stock move -1.05% to $53.45, representing a per-share move of $0.5649, on volume of 7.47 million shares for Tuesday. Merck & Co. Inc. currently has a total float of 2.79 billion shares and moves n/a a …
Equities · 1 day ago
stock market
Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report BRISTOL-MYERS (BMY): Free Stock Analysis Report BIOGEN INC (BIIB): Free Stock Analysis Report MERCK & CO INC (MRK): Free Stock Analysis Report
Yahoo Finance · 2 hours ago
metastatic melanoma
[Reuters] – Merck & Co said an independent data monitoring committee recommended that the drugmaker continue a study of its experimental cholesterol drug, anacetrapib. The recommendation comes a month after …
Jutia Group · 11/13/2015
cholesterol drug
prompting some investing experts at the moment to favor JNJ stock over PFE. Johnson & Johnson is well-known for its consumer brands, while Pfizer is more often compared with purer-play drugmakers Merck & Co.
USNews · 11/19/2015
Johnson Johnson
Merck KGaA (FRA:MRK) has been assigned a €100.00 ($107.53) price target by research analysts at Citigroup Inc. in a research note issued to investors on Thursday, reports. The brokerage currently has a a “buy” rating on the stock.
Intercooler · 11/16/2015
Merck KGaA
Shares of Merck KGaA (FRA:MRK) have earned an average rating of “Hold” from the fourteen research firms that are presently covering the firm, Market Beat Ratings reports. One research analyst has rated the stock
Watch List News · 11/21/2015
Merck KGaA
Shares closed Monday at $84.74. This top company remains a leading healthcare stock that is on the focus lists of many of the firms we cover. Merck & Co. Inc. (NYSE: MRK) sells numerous prescription medicines, vaccines, biologic therapies, and …
24/7 Wall ST · 1 day ago
Merrill Lynch
Merck & Co Inc (MRK) current short interest stands at 27.83 million shares. Argus now has a $65.00 price objective on the stock, down from their prior price objective of $70.00. Several other equities analysts have also commented on MKGAY. DZ Bank AG ... · 11/20/2015
Merck KGaA

Merck & Co.

Merck & Co., Inc., d.b.a. Merck Sharp & Dohme outside the United States and Canada, is an American pharmaceutical company and one of the l…
Merck & Co., Inc., d.b.a. Merck Sharp & Dohme outside the United States and Canada, is an American pharmaceutical company and one of the largest pharmaceutical companies in the world. Merck headquarters is located in Kenilworth, New Jersey. The company was established in 1891 as the United States subsidiary of the German company Merck. Merck & Co. was confiscated by the US government during World War I and subsequently established as an independent American company. It is the world's seventh largest pharmaceutical company by market capitalization and revenue.
Data from: Wikipedia · Freebase